These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 22753600

  • 21. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J, Frolov I, Russell SJ.
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [Abstract] [Full Text] [Related]

  • 22. Rapid, high level protein production using DNA-based Semliki Forest virus vectors.
    DiCiommo DP, Bremner R.
    J Biol Chem; 1998 Jul 17; 273(29):18060-6. PubMed ID: 9660762
    [Abstract] [Full Text] [Related]

  • 23. Live viral vectors: Semliki Forest virus.
    Karlsson GB, Liljeström P.
    Methods Mol Med; 2003 Jul 17; 87():69-82. PubMed ID: 12958450
    [No Abstract] [Full Text] [Related]

  • 24. Expression of additional genes in a vector derived from a minimal RNA virus.
    Rolls MM, Haglund K, Rose JK.
    Virology; 1996 Apr 15; 218(2):406-11. PubMed ID: 8610469
    [Abstract] [Full Text] [Related]

  • 25. Alphavirus DNA and particle replicons for vaccines and gene therapy.
    Polo JM, Gardner JP, Ji Y, Belli BA, Driver DA, Sherrill S, Perri S, Liu MA, Dubensky TW.
    Dev Biol (Basel); 2000 Apr 15; 104():181-5. PubMed ID: 11713818
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic and prophylactic applications of alphavirus vectors.
    Atkins GJ, Fleeton MN, Sheahan BJ.
    Expert Rev Mol Med; 2008 Nov 11; 10():e33. PubMed ID: 19000329
    [Abstract] [Full Text] [Related]

  • 27. Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest virus.
    Del Vecchio C, Calistri A, Lombardi G, Celegato M, Biasolo MA, Palù G, Parolin C.
    Gene Ther; 2009 Feb 11; 16(2):279-90. PubMed ID: 19037240
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.
    Withoff S, Glazenburg KL, van Veen ML, Kraak MM, Hospers GA, Störkel S, de Vries EG, Wilschut J, Daemen T.
    Gene Ther; 2001 Oct 11; 8(20):1515-23. PubMed ID: 11704811
    [Abstract] [Full Text] [Related]

  • 30. Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells.
    Zhang J, Asselin-Paturel C, Bex F, Bernard J, Chehimi J, Willems F, Caignard A, Berglund P, Liljeström P, Burny A, Chouaib S.
    Gene Ther; 1997 Apr 11; 4(4):367-74. PubMed ID: 9176524
    [Abstract] [Full Text] [Related]

  • 31. Alphaviral cytotoxicity and its implication in vector development.
    Rhême C, Ehrengruber MU, Grandgirard D.
    Exp Physiol; 2005 Jan 11; 90(1):45-52. PubMed ID: 15542620
    [Abstract] [Full Text] [Related]

  • 32. Expression of proteins using Semliki Forest virus vectors.
    Liljeström P, Garoff H.
    Curr Protoc Mol Biol; 2001 May 11; Chapter 16():Unit16.20. PubMed ID: 18265128
    [Abstract] [Full Text] [Related]

  • 33. Recombination of replicon and helper RNAs and the emergence of propagation-competent vectors upon Sindbis virus vector production.
    Hyvärinen A, Yongabi F, Mäkinen K, Wahlfors J, Pellinen R.
    Int J Mol Med; 2013 Aug 11; 32(2):410-22. PubMed ID: 23716190
    [Abstract] [Full Text] [Related]

  • 34. Sindbis vectors suppress secretion of subviral particles of Japanese encephalitis virus from mammalian cells infected with SIN-JEV recombinants.
    Pugachev KV, Mason PW, Frey TK.
    Virology; 1995 May 10; 209(1):155-66. PubMed ID: 7747465
    [Abstract] [Full Text] [Related]

  • 35. High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules.
    Zeng J, Fournier P, Schirrmacher V.
    Int J Oncol; 2004 Aug 10; 25(2):293-302. PubMed ID: 15254725
    [Abstract] [Full Text] [Related]

  • 36. Alphavirus vectors for cancer gene therapy (review).
    Yamanaka R.
    Int J Oncol; 2004 Apr 10; 24(4):919-23. PubMed ID: 15010830
    [Abstract] [Full Text] [Related]

  • 37. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF.
    Virology; 1997 Dec 22; 239(2):389-401. PubMed ID: 9434729
    [Abstract] [Full Text] [Related]

  • 38. Recombination of nonreplicative RNA precursors of Sindbis virus in infected cells overexpressing murine-inducible nitric oxide synthase.
    Herrmann A, Müller G, Gödecke A, Schrader J.
    Biochem Biophys Res Commun; 1998 Dec 18; 253(2):524-31. PubMed ID: 9878569
    [Abstract] [Full Text] [Related]

  • 39. Soluble expression and complex formation of proteins required for HCMV DNA replication using the SFV expression system.
    McCue LA, Anders DG.
    Protein Expr Purif; 1998 Aug 18; 13(3):301-12. PubMed ID: 9693054
    [Abstract] [Full Text] [Related]

  • 40. Semliki forest virus-based expression of recombinant GPCRs.
    Lundstrom K.
    Methods Enzymol; 2015 Aug 18; 556():331-50. PubMed ID: 25857789
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.